Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc.verified

ETON

Price:

$16.81

Market Cap:

$450.80M

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in c...[Read more]

Industry

Biotechnology

IPO Date

2018-11-13

Stock Exchange

NASDAQ

Ticker

ETON

The ROE as of December 2025 (TTM) for Eton Pharmaceuticals, Inc. (ETON) is -27.85%

According to Eton Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -27.85%. This represents a change of 297.91% compared to the average of -7.00% of the last 4 quarters.

Eton Pharmaceuticals, Inc. (ETON) Historical ROE (quarterly & annually)

How has ETON ROE performed in the past?

The mean historical ROE of Eton Pharmaceuticals, Inc. over the last ten years is -70.18%. The current -27.85% ROE has changed -60.31% with respect to the historical average. Over the past ten years (40 quarters), ETON's ROE was at its highest in in the June 2023 quarter at 27.26%. The ROE was at its lowest in in the September 2020 quarter at -468.59%.

Quarterly (TTM)
Annual

Average

-70.18%

Median

-53.71%

Minimum

-178.57%

Maximum

-6.05%

Eton Pharmaceuticals, Inc. (ETON) ROE by Quarter and Year

Discovering the peaks and valleys of Eton Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 522.04%

Maximum Annual ROE = -6.05%

Minimum Annual Increase = -93.79%

Minimum Annual ROE = -178.57%

Quarterly (TTM)
Annual
YearROEChange
2024-15.65%158.78%
2023-6.05%-91.23%
2022-68.98%522.04%
2021-11.09%-93.79%
2020-178.57%2.84%
2019-173.65%258.52%
2018-48.44%-17.90%

Eton Pharmaceuticals, Inc. (ETON) Average ROE

How has ETON ROE performed in the past?

The current ROE of Eton Pharmaceuticals, Inc. (ETON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-30.23%

5-year avg

-56.07%

10-year avg

-70.18%

Eton Pharmaceuticals, Inc. (ETON) ROE vs. Peers

How is ETON’s ROE compared to its peers?

Eton Pharmaceuticals, Inc.’s ROE is greater than RAPT Therapeutics, Inc. (-61.81%), greater than Fulcrum Therapeutics, Inc. (-32.17%), greater than Neumora Therapeutics, Inc. Common Stock (-113.81%), greater than Lexicon Pharmaceuticals, Inc. (-83.63%), less than Omeros Corporation (57.33%), greater than Ocugen, Inc. (-255.25%), greater than Monopar Therapeutics Inc. (-9.75%), greater than Lineage Cell Therapeutics, Inc. (-119.44%), less than ADC Therapeutics S.A. (82.24%), greater than Bicycle Therapeutics plc (-35.54%),

Build a custom stock screener for Eton Pharmaceuticals, Inc. (ETON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eton Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eton Pharmaceuticals, Inc. (ETON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eton Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Eton Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Eton Pharmaceuticals, Inc. (ETON)?

What is the highest ROE for Eton Pharmaceuticals, Inc. (ETON)?

What is the 3-year average ROE for Eton Pharmaceuticals, Inc. (ETON)?

What is the 5-year average ROE for Eton Pharmaceuticals, Inc. (ETON)?

How does the current ROE for Eton Pharmaceuticals, Inc. (ETON) compare to its historical average?